Medicus Pharma Ltd MDCX
0.15
(0.01)
(6.25%)
as of 25 Sep
- Market cap
- $10.0M
- P/E
- 0.0×
Follow MDCX
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(2,660.03%) | (2,981.87%) | (2,877.17%) | (7,441.07%) | |
| (455.33%) | (602.13%) | (786.20%) | (290.34%) | ||
ROIC |
0.00% | 0.00% | 0.00% | (2,497.51%) | |
Return on Tangible Assets |
4,077.59% | 99,562.95% | (3,870.91%) | (923.27%) | |
Free Cash Flow per Share |
(1.04) | (1.32) | (0.94) | (0.53) | |
Free Cash Flow |
(19.36) | (22.78) | (27.81) | (29.32) | |
Piotroski F-Score |
1.00 | 1.00 | 1.00 | 2.00 | |
| Other line items | |||||
Cash ROIC |
(246.39%) | (260.53%) | (356.78%) | (93.28%) | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.54 | 0.48 | 0.54 | 0.52 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(1.04) | (1.32) | (0.94) | (0.53) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates